SCHEMBL6498775

SCHEMBL6498775

CCOC(=O)c1c(N)c(C(N)=O)nn1-c1ccc(Br)cc1CC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 3/20 0.51
HPGD P15428 1/20 0.51
HSD17B10 Q99714 1/20 0.51
ELANE P08246 4/20 0.41
GABRG2 P18507 5/20 0.38
GABRB3 P28472 5/20 0.38
GABRA5 P31644 5/20 0.38
GABRA2 P47869 3/20 0.38
GABRA1 P14867 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA6 Q16445 2/20 0.38
MAPT P10636 3/20 0.38
GABRB2 P47870 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6502036 0.86 HPGD (0.36) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL6500566 0.79 KDM4E (0.52) KDM4EALDH1A1HPGDHSD17B10ELANE
SCHEMBL6469895 0.76 ALDH1A1 (0.51) KDM4EALDH1A1HPGDHSD17B10ELANE
SCHEMBL6469689 0.75 ALDH1A1 (0.56) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL6467658 0.74 ALDH1A1 (0.55) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL6504869 0.74 ALDH1A1 (0.54) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL6508436 0.74 ALDH1A1 (0.66) KDM4EALDH1A1HPGDHSD17B10ELANE
SCHEMBL6470216 0.73 ALDH1A1 (0.53) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL6500282 0.72 ALDH1A1 (0.58) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL6470606 0.71 ALDH1A1 (0.56) KDM4EALDH1A1HPGDHSD17B10GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 KDM4E 2424/4885ALDH1A1 846/4885HPGD 1845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.